MENU
CLOSE
Home
News
2016 Announcements
Page 4
2016 Announcements
Filters:
Category
Latest
2016 Announcements
2017 Announcements
2018 Announcements
2019 Announcements
2020 Announcements
2021 Announcements
2022 Announcements
2023 Announcements
2024 Announcements
Clinical
Corporate
Financial
News
Newsletter
Pages
Presentation
Recruitment
Regulatory
Stories
Form 604 – March 15, 2016
2016 Announcements
15.03.2016
CLINUVEL accredits first European EPP expert centres
2016 Announcements
13.03.2016
CLINUVEL placement of A$8.3 million completed successfully
2016 Announcements
13.03.2016
Request for Trading Halt
2016 Announcements
11.03.2016
Appendix 4D and Half Year Report
2016 Announcements
19.02.2016
CLINUVEL brief on European commercialisation
2016 Announcements
13.02.2016
SCENESSE® receives US FDA orphan designation for cutaneous porphyrias
2016 Announcements
10.02.2016
Presentation to international porphyria patient group
2016 Announcements
07.02.2016
Appendix 4C – Q2 FY16
2016 Announcements
28.01.2016
Form 604
2016 Announcements
25.01.2016
CEO Brief – January 20, 2016
2016 Announcements
20.01.2016
Form 604
2016 Announcements
18.01.2016
.
‹
1
2
3
4
About
About CLINUVEL
People
Corporate Governance
Photomedicine Foundation
Annual Reports
Pharmaceuticals
About Pharmaceuticals
The Science
Disease Entities
Products
PhotoCosmetics
About PhotoCosmetics
Polychromatic Photoprotection
DNA Repair
Melanogenesis
Investors
Investors Information
ASX Announcements
Analyst Coverage
Media Coverage
Company Snapshot
Financial Summary
Shareholder Information
Investor Enquiry
News
Contact
Store
Go To Top